4.3 Article

Triton X-100 inhibits L-type voltage-operated calcium channels

Journal

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
Volume 91, Issue 4, Pages 316-324

Publisher

CANADIAN SCIENCE PUBLISHING
DOI: 10.1139/cjpp-2012-0257

Keywords

Triton X-100; voltage-operated calcium channel; vascular smooth muscle; cardiac myocyte; pancreatic beta-cell

Funding

  1. Canadian Institutes of Health Research [MOP77529, MOP 37945]
  2. Heart and Stroke Foundation of Canada
  3. University of Alberta Faculty of Medicine and Dentistry
  4. CIHR Banting and Best Masters Award

Ask authors/readers for more resources

Triton X-100 (TX-100) is a nonionic detergent frequently used at millimolar concentrations to disrupt cell membranes and solubilize proteins. At low micromolar concentrations, TX-100 has been reported to inhibit the function of potassium channels. Here, we have used electrophysiological and functional techniques to examine the effects of TX-100 on another class of ion channels, L-type voltage-operated calcium channels (VOCCs). TX-100 (30 nmol.L-1 to 3 mu mol.L-1) caused reversible concentration-dependent inhibition of recombinant L-type VOCC (Ca-V 1.2) currents and of native L-type VOCC currents recorded from rat vascular smooth muscle cells and cardiac myocytes, and murine and human pancreatic beta-cells. In functional studies, TX-100 (165 nmol.L-1 to 3.4 mu mol.L-1) caused concentration-dependent relaxation of rat isolated mesenteric resistance arteries prestimulated with phenylephrine or KCl. This effect was independent of the endothelium. TX-100 (1.6 mu mol.L-1) inhibited depolarization-induced exocytosis in both murine and human isolated pancreatic beta-cells. These data indicate that at concentrations within the nanomolar to low micromolar range, TX-100 significantly inhibits L-type VOCC activity in a number of cell types, an effect paralleled by inhibition of cell functions dependent upon activation of these channels. This inhibition occurs at concentrations below those used to solubilize proteins and may compromise the use of solutions containing TX-100 in bioassays.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available